Quality & complianceOfficial

Estonian regulator warns of counterfeit GC Tooth Mousse that may contain cleaning-product substances

🇪🇪 Ravimiamet · Tue 03 Nov 2026

Ravimiamet says a falsified version of the dental cream, sold via Poland's Allegro platform, may have reached Estonia and could contain agents not meant for use in the mouth.

Ravimiamet, the Estonian State Agency of Medicines, has warned that a counterfeit version of the dental cream GC Tooth Mousse has been identified on the EU market. The agency says the fake product may contain substances hazardous to health.

According to the agency, the counterfeit was sold on the Polish online platform Allegro but may also have reached Estonia. It advises consumers to be attentive and not to use the product if they suspect it is falsified.

The genuine product is intended to protect and strengthen teeth. Among other uses, it reduces tooth sensitivity and protects enamel. Analysis of the counterfeit indicates it may contain substances used in cleaning products, including those found in Ajax Cleaner Powder – Oxygen Bleach and Comet Disinfecting Cleaner with Bleach. Ravimiamet says these are not intended for use in the mouth and may cause harm if absorbed through mucous membranes or swallowed.

The agency says differences in packaging and labelling between the original and the fake can help identify a suspect product, and it has published comparison images. Anyone who has bought the product and suspects a counterfeit should not use it or pass it on, and should report it to the agency's medical devices department by email, ideally with photos of the product and packaging and details of where it was bought. Those who have already used a suspect product and developed health complaints are advised to see a doctor.

What it means for your team

  • Quality and anti-counterfeiting teams should check whether GC Tooth Mousse is sold through online marketplaces in their supply chains, particularly Allegro.
  • Companies handling oral-care or dental products should be ready to point customers to packaging and labelling differences between genuine and falsified goods.
  • Vigilance teams should be aware that suspected adverse health effects linked to the product should be directed to a doctor and reported to the national authority's medical devices department.

Official source: Ravimiamet ↗

Article written by VigiEye from the official source (Ravimiamet). AI-assisted; check the source before acting.

More Quality & compliance All →